Trade

with

Fennec Pharmaceuticals Inc
(Toronto: FRX)
AdChoices
2.50
+0.01
+0.40%
After Hours :
-
-
-

Open

0.0000

Previous Close

2.49

Volume (Avg)

133 (8.64k)

Day's Range

0.0000-0.0000

52Wk Range

2.10-3.99

Market Cap.

-

Dividend Rate ( Yield )

-

Beta

-0.94

Shares Outstanding

9.86M

P/E Ratio (EPS)

-

AdChoices
Financials
  • Income Statement
  • Balance Sheet
  • Cash Flow
Operating Income
-2.17M
Operating Margin
-
Total Equity
-
Retained Earnings
-
Free Cashflow
-
Price/Cashflow
-
Company Profile

Sector

Healthcare

Industry

Biotechnology

Type

-

Style

Small Value

Fennec Pharmaceuticals Inc is a development stage biotechnology company. It is engaged in developing cancer therapeutics. Its products which are in the clinical stage of development are Sodium Thiosulfate and Eniluracil.

Key People

Mr. Rostislav Raykov

CEO/Chairman of the Board/Director

Ms. Krysia Lynes

CFO

Steven D. Skolsky

Director

Chris A. Rallis

Director

Dr. Khalid Islam

Director

Incorporated

1996

Employees

-